Skip to main content
. 2017 May 12;51(3):215–222. doi: 10.1016/j.aott.2017.02.001

Table 3.

Preoperative characteristics of the included studies.

PS
ST
n Implant M F Age BMI n Implant M F Age BMI
Abane 70 Genesis II 41 29 67.8 28.8 70 Genesis II 43 28 70.4 28.6
Boonen 86 Vanguard 34 56 69 30.3 82 Vanguard 40 50 65 29.5
Chareanc. 40 NexGen 6 34 69.5 27.7 40 NexGen 4 36 70.3 28
Hamilton 26 TruMatch 14 21 68.1 30.9 26 NS 7 19 67.6 31.1
Kotela 49 Vanguard 16 33 66.1 30.0 46 Vanguard 13 33 68.6 29.6
Parratte 20 NexGen NS NS NS NS 20 NexGen NS NS NS NS
Pfitzner 60 TruMatch/Visionaire 26 34 64 30 30 Journey BCS 13 17 64 31
Roh 42 Vanguard 3 39 70 27 48 Vanguard 5 43 70 27
Victor 64 Biomet PS 21 43 67 NS 64 Biomet PS 21 43 66 NS
Woolson 30 TruMatch NS NS NS NS 33 NS NS NS NS NS
Yan 30 NS 13 17 67.5 NS 30 NS 7 23 69.8 NS
Chotanaphuti 40 TruMatch NS NS 69.7 25 40 Sigma NS NS 69.3 25

n = number of cases, M = male, F = female, BMI = Body mass index, NS = Not specified.